首页> 外国专利> 2 - oximino - 17ª - hydroxy - 17ª ≠ - methyl - 3 - ketostatines steroids of androstane series and a process for their production

2 - oximino - 17ª - hydroxy - 17ª ≠ - methyl - 3 - ketostatines steroids of androstane series and a process for their production

机译:2-肟基-17ª%-羟基-17ª≠-甲基-3-酮斯坦汀类雄激素系列甾族化合物及其生产方法

摘要

Novel steroids of the formulae FORM:1065237/C2/1 FORM:1065237/C2/2 FORM:1065237/C2/3 (wherein R1 is hydrogen, halogen, or hydroxy, but is not halogen or hydroxy in compounds I; R2 is hydrogen or methyl; R3 is hydrogen or alkyl; R4 is hydrogen, keto or b -hydroxy; R5 is hydrogen, alkyl, alkenyl, o -haloalkynyl or alkynyl; R6 is hydrogen, alkanoyl, aralkanoyl cycloalkylalkanoyl or chlorophenoxyalkanoyl; R7 is hydrogen, halogen or alkyl, but is not halogen in compounds I and II; and X is hydrogen or halogen) are prepared by reacting the corresponding 2-hydroxymethylene steroids with nitrous acid. Steroids of the formula FORM:1065237/C2/4 are prepared from the corresponding 2-unsubstituted steroids and alkyl formates. Free hydroxy groups may be formylated in this process. 7a ,17a - Dimethyl - 17b - hydroxy - 19 - norandrostan-3-one is prepared by reacting 17b -hydroxy - 17a - methyl - 19 - norandrosta - 4,6-dien-3-one with methyl magnesium bromide to give 7a ,17a - dimethyl - and 7b ,17a - dimethyl-17b - hydroxy - 19 - nor - androst - 4 - en - 3 - ones and reducing the 7a -compound. The corresponding 17a -ethyl compounds are prepared similarly. 17b - Hydroxy - androstan - 3 - one 17b - (3-phenyl-propionate) is prepared by reduction of the D 4-compound. 4,17 - Dihydroxy - 17a - methyl - androst - 4-en - 3 - one is prepared by stirring 4b ,5-epoxy - 17b - hydroxy - 17a - methylandrostan-3-one (prepared from the androst-4-ene compound and H2O2) with glacial acetic acid and sulphuric acid. The corresponding 4-chloro compound is prepared from the 4,5-epoxide and glacial acetic saturated with hydrogen chloride.
机译: 的新型类固醇(其中R1为氢,卤素或羟基,但不是卤素或羟基化合物I; R 2为氢或甲基; R 3为氢或烷基; R 4为氢,酮或b-羟基; R 5为氢,烷基,烯基,邻卤代炔基或炔基; R 6为氢,烷酰基,芳烷酰基环烷基烷酰基或氯苯氧基烷酰基;在化合物I和II中,R 7是氢,卤素或烷基,但不是卤素;并且X是氢或卤素)是通过使相应的2-羟基亚甲基类固醇与亚硝酸反应制备的。式的类固醇由相应的2-未取代的类固醇和烷基甲酸酯制备。游离羟基可在该过程中被甲酰化。 7a,17a-通过使17b-羟基-17a-甲基-19-norandrosta-4,6-dien-3-one与甲基溴化镁反应制得7a,17a-二甲基-17b-羟基-19-去氧雄甾烷-3-酮17a-二甲基-和7b,17a-二甲基-17b-羟基-19-或-androst-4-en-3-并还原7a-化合物。类似地制备相应的17a-乙基化合物。通过还原D 4-化合物制备17b-羟基-雄甾烷3-1-17b-(3-苯基丙酸酯)。通过搅拌4b,5-环氧-17b-羟基-17a-甲基Androstan-3-one(由androst-4-ene化合物制得)制备4,17-二羟基-17a-甲基-雄酮-4-en-3-1和H2O2)与冰醋酸和硫酸。相应的4-氯化合物是由4,5-环氧化物和用氯化氢饱和的冰醋酸制备的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号